The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 5
  • 1
    Rees, Richard John
    Cfo born in May 1976
    Individual (5 offsprings)
    Officer
    2018-02-08 ~ now
    OF - director → CIF 0
  • 2
    Craven, Richard Gary
    Individual (3 offsprings)
    Officer
    2018-02-08 ~ now
    OF - secretary → CIF 0
  • 3
    Hancock, Christopher Paul, Prof
    Cto born in March 1967
    Individual (7 offsprings)
    Officer
    2018-02-08 ~ now
    OF - director → CIF 0
  • 4
    Gulliford, Craig Jonathan
    Ceo born in May 1970
    Individual (5 offsprings)
    Officer
    2018-02-08 ~ now
    OF - director → CIF 0
  • 5
    MICROONCOLOGY LTD - 2010-08-10
    Creo House, Unit 2 Beaufort Park, Beaufort Park Way, Chepstow, Wales, United Kingdom
    Corporate (5 parents, 1 offspring)
    Total Assets Less Current Liabilities (Company account)
    3,234,602 GBP2016-02-29
    Person with significant control
    2018-02-08 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
parent relation
Company in focus

CREO MEDICAL INNOVATIONS LIMITED

Standard Industrial Classification
72190 - Other Research And Experimental Development On Natural Sciences And Engineering
Brief company account
Debtors
2,163,178 GBP2023-12-31
2,199,300 GBP2022-12-31
Cash at bank and in hand
1 GBP2023-12-31
1 GBP2022-12-31
Current Assets
2,163,179 GBP2023-12-31
2,199,301 GBP2022-12-31
Net Current Assets/Liabilities
2,163,179 GBP2023-12-31
2,199,301 GBP2022-12-31
Total Assets Less Current Liabilities
2,163,179 GBP2023-12-31
2,199,301 GBP2022-12-31
Creditors
Amounts falling due after one year
-2,137,697 GBP2023-12-31
-2,177,729 GBP2022-12-31
Net Assets/Liabilities
25,482 GBP2023-12-31
21,572 GBP2022-12-31
Equity
Called up share capital
1 GBP2023-12-31
1 GBP2022-12-31
Retained earnings (accumulated losses)
25,481 GBP2023-12-31
21,571 GBP2022-12-31
Equity
25,482 GBP2023-12-31
21,572 GBP2022-12-31
Average Number of Employees
02023-01-01 ~ 2023-12-31
02022-01-01 ~ 2022-12-31
Debtors
Amounts falling due after one year
2,163,178 GBP2023-12-31
2,199,300 GBP2022-12-31

  • CREO MEDICAL INNOVATIONS LIMITED
    Info
    Registered number 11196260
    Creo House Unit 2, Beaufort Park, Beaufort Park Way, Chepstow NP16 5UH
    Private Limited Company incorporated on 2018-02-08 (7 years 4 months). The company status is Active.
    The last date of confirmation statement was made at 2025-02-07
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.